sever
acut
respiratori
syndrom
sar
newli
emerg
infecti
diseas
caus
novel
coronaviru
sarscov
overwhelm
countri
claim
nearli
case
fatal
thank
unpreced
intern
collabor
wholegenom
sarscov
success
deciph
shortli
identif
caus
pathogen
outbreak
sar
southern
china
hitherto
sarscov
viral
paradigm
emerg
infecti
entiti
extens
studi
rang
epidemiolog
molecular
virologyimmunolog
structur
genom
also
sever
line
breakthrough
recordbrokenli
obtain
includ
find
function
receptor
sarscov
solut
pro
structur
first
crystal
structur
sarsrel
macromolecul
reveal
bat
natur
reservoir
sarslik
virus
possibl
involv
civet
cat
sar
emerg
review
intend
outlin
major
progress
journey
articl
press
wwwelseviercomlocatecimid
see
front
matter
r
e
syndrom
respiratoir
aigu
sra
ou
sar
une
maladi
infectieus
par
un
nouveau
coronaviru
sarscov
toucha
plu
de
personn
causant
mort
dan
pay
la
mise
en
place
dune
collabor
international
san
le
du
complet
du
sarscov
fut
peu
de
temp
apr
lidentif
de
lagent
pathog
ne
suit
au
de
l
dan
le
sud
de
la
chine
en
le
sarscov
en
temp
que
paradigm
de
maladi
infectieus
fait
lobjet
dune
compl
te
en
passant
de
l
la
virologieimmunologi
la
structural
ainsi
cest
en
un
temp
record
quont
de
majeur
incluant
la
de
un
fonctionnel
pour
le
sarscov
la
structur
du
pro
premi
structur
cristallographiqu
dune
du
sar
que
la
chauvesouri
le
naturel
de
viru
du
type
sar
et
que
la
civett
certain
lorigin
de
l
du
sra
cett
revu
vise
soulign
le
progr
majeur
dan
lexplor
du
sra
en
soulign
limport
de
travaux
primordiaux
et
par
le
chercheur
chinoi
r
sever
acut
respiratori
syndrom
sar
also
initi
call
atyp
pneumonia
china
recogn
emerg
infecti
diseas
ever
pose
great
threat
public
health
even
result
global
panic
extent
unusu
diseas
first
recogn
guangdong
provinc
china
novemb
character
seri
clinic
manifest
includ
high
fever
short
breath
cough
pneumonia
subsequ
spread
asian
countri
north
america
europ
juli
epidem
affect
least
countri
across
contin
infect
person
announc
fatal
mention
first
epidem
sar
end
juli
announc
world
health
organ
sporad
new
case
report
realli
rare
unlik
case
laboratori
infect
report
singapor
taiwan
beij
four
confirm
sar
patient
episod
guangzhou
china
communityinfect
case
without
obviou
humantohuman
contact
histori
relat
sar
collect
sar
devast
profoundli
social
econom
activ
region
well
global
howev
also
quickli
defeat
great
effort
intern
commun
thank
unpreced
global
collabor
coordin
sarscov
novel
member
coronavirida
famili
rapidli
confirm
aetiolog
agent
sar
epidem
excitedli
complet
genom
sequenc
two
differ
group
within
week
isol
viru
subsequ
molecular
epidemiolog
sarscov
base
genom
approach
bioinformat
indic
coevolut
episod
ongo
period
circul
sever
typic
molecular
characterist
meanwhil
classic
epidemiolog
survey
impli
sarscov
may
anim
origin
precursor
still
present
anim
popul
furthermor
liveanim
market
southern
china
suggest
provid
animalhuman
interfac
allow
precursor
viru
adapt
humanhuman
interspeci
transmiss
shortli
definit
sarscov
entiti
multipl
line
investig
molecular
level
carri
aim
develop
effect
approach
diagnost
control
prevent
sar
well
present
comprehens
knowledg
interplay
sarscov
host
noteworthi
sever
mileston
find
harvest
includ
angiotensinconvert
enzym
function
receptor
util
sarscov
entri
host
cell
crystal
structur
pro
key
enzym
involv
sarscov
life
cycl
attract
drug
target
sar
therapeut
molecular
coevolut
sarscov
bat
natur
host
reservoir
sarscov
time
write
review
octob
number
literatur
concern
sar
expand
item
pubm
wwwncbinlmnihgov
indic
strongli
seriou
attent
ever
paid
emerg
infecti
diseas
luckili
diseas
mysteri
disappear
great
effort
far
sever
excel
review
document
issu
sar
therefor
reader
kindli
remind
attempt
provid
outlin
sar
research
epidemiolog
molecular
virolog
vaccin
develop
major
progressbreakthrough
contribut
chines
scientist
especi
emphas
review
sharpli
accumul
knowledg
sar
profoundli
facilit
perform
clinic
diagnosi
suspect
case
period
atyp
pneumonia
better
defin
sar
case
follow
criteria
propos
close
contact
patient
infect
peopl
fever
symptom
respiratori
ill
leukocyt
count
l
radiograph
evid
infiltr
consist
pneumonia
respiratori
distress
syndrom
chest
xray
respons
antimicrobi
drug
treatment
within
h
gener
peopl
diagnos
suspect
sar
patient
met
criteria
exclud
altern
diagnosi
could
fulli
explain
ill
typic
incub
period
sar
rang
day
may
occasion
long
day
prodrom
includ
influenzalik
symptom
fever
myalgia
headach
diarrhea
onset
diseas
case
progress
moderatesever
variant
character
seriou
later
respiratori
phase
dyspnea
exert
rest
hypoxia
casefat
rate
outbreak
nearli
rang
gener
pulmonari
lesion
sar
patient
frequent
diagnos
diffus
alveolar
damag
follow
histolog
chang
includ
compos
desquam
pneumocyt
format
hyalin
membran
flood
alveolar
lumina
oedema
fluid
mix
inflammatori
cell
presenc
enlarg
pneumocyt
syncytia
also
alveolar
wall
thicken
mild
mononuclear
infiltr
later
stage
air
space
contain
fibromyxoidorgan
exud
aid
transmiss
electron
microscopi
viruslik
particl
observ
cell
lung
biopsi
specimen
bronchoalveolar
lavag
sampl
pneumocyt
postmortem
lung
sampl
judg
base
koch
postul
causal
pathogen
respons
atyp
pneumonia
quickli
determin
novel
member
group
ii
coronavirus
call
sarscov
sever
acut
respiratori
syndromerel
coronaviru
famili
coronavirida
fig
envelop
positivesens
singlestrand
ss
rna
viru
featur
larg
genom
approxim
kb
fig
b
subsequ
genom
annot
reveal
may
consist
function
open
read
frame
orf
encod
three
class
protein
two
larg
polyprotein
cleav
nonstructur
protein
nsp
essenti
viral
rna
synthesi
four
structur
protein
surfac
envelop
e
matrix
nucleocapsid
n
protein
requir
viral
assembl
eight
accessori
protein
may
confer
select
advantag
infect
host
tabl
fig
similar
coronavirus
protein
sarscov
divid
amino
carboxyl
region
subunit
mediat
bind
receptor
subunit
respons
membran
fusion
viru
host
cell
protein
sarscov
also
suggest
account
induc
host
immun
respons
product
neutral
antibodi
high
virul
etc
doubt
sarscov
emerg
infecti
entiti
evolv
possess
capabl
overcom
interspeci
barrier
caus
seriou
panic
worldwid
field
public
health
howev
remain
unclear
disrupt
natur
ecolog
balanc
system
make
viru
jump
natur
reservoir
adapt
human
host
molecular
mechan
underli
mysteri
great
need
scientif
commun
seem
common
notion
sar
origin
guangdong
provinc
southern
china
worldwid
spread
trigger
singl
individu
socal
superspread
time
infect
guangdong
spent
time
hong
kong
succumb
sar
period
unwittingli
infect
other
turn
caus
seri
sar
outbreak
toronto
canada
area
around
world
eventu
nearli
month
travel
less
countri
area
world
pass
sever
gener
reflect
genet
variat
sarscov
attempt
discuss
trace
origin
sarscov
well
gener
rule
molecular
evolut
epidem
retrospect
sever
index
sar
case
earliest
record
foshan
citi
guangdong
provinc
china
novemb
found
share
common
featur
typic
histori
contact
anim
food
industri
critic
clue
prompt
initi
field
epidemiolog
investig
mainli
liveanim
market
guangdong
provinc
unexpectedli
liveanim
market
examin
wild
anim
trader
slaughter
reveal
seroposit
sarscov
led
specul
sar
may
zoonot
unknown
anim
reservoir
subsequ
suspicion
focus
palm
civet
due
fact
sar
seroposit
among
trader
primarili
trade
mask
palm
civet
fortun
sarslik
virus
success
isol
himalayan
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
anim
market
shenzhen
citi
china
moreov
analysi
viral
genom
show
homolog
sarscov
find
establish
strongli
basi
anim
origin
sarscov
also
result
largescal
cull
civet
prevent
reemerg
sar
area
howev
subsequ
survey
fail
observ
evid
support
widespread
infect
sarscov
wild
andor
farm
civet
addit
experiment
infect
civet
human
isol
sarscov
reproduc
overt
clinic
symptom
similar
sar
patient
rule
possibl
civet
play
role
natur
reservoir
host
sarscov
rather
suscept
host
nevertheless
civet
may
ever
carrier
sourc
sarslik
viru
precipit
sar
outbreak
exist
virus
common
anim
within
wetmarket
system
southern
china
seem
like
reflect
artifici
market
cycl
nativ
speci
indic
natur
reservoir
viru
therebi
endless
search
origin
sarscov
ongo
paid
much
attent
candid
anim
excitedli
mysteri
mask
recent
unveil
li
et
al
bat
function
natur
reservoir
sarslik
coronavirus
fig
fact
bat
ever
recogn
natur
host
sever
zoonot
virus
hendra
nipah
virus
recent
emerg
australia
east
asia
respect
also
bat
rare
display
clinic
symptom
even
though
persist
infect
multipl
virus
moreov
increas
util
bat
product
food
tradit
medicin
market
especi
southern
china
elsewher
asia
make
possibl
sarslik
virus
jump
human
bat
subsequ
adapt
human
final
trigger
humantohuman
transmiss
result
global
outbreak
sar
multipl
line
investig
focus
molecular
epidemiolog
sarscov
present
gener
rule
sarscov
differ
cours
sar
epidem
base
wide
rang
sequenc
analysi
differ
sarscov
isol
guan
group
postul
sarscov
may
total
divid
two
distinct
cluster
one
genotyp
link
infect
origin
hotel
hong
kong
one
compris
isol
hong
kong
guangdong
beij
associ
hotel
date
inform
whether
differ
sarscov
strain
may
differ
degre
virul
addit
zhao
group
carri
intens
compar
genom
studi
sequenc
whole
genom
isol
sarscov
deriv
earli
middl
late
phase
sra
epidem
well
two
viral
genom
palm
civet
excit
find
show
earliest
genotyp
similar
anim
sarslik
coronavirus
major
delet
observ
start
end
epidem
neutral
mutat
rate
genom
constant
amino
acid
substitut
rate
cd
slow
epidem
period
protein
present
robust
initi
respons
posit
select
pressur
follow
select
purif
eventu
stabil
gener
comprehens
analysi
provid
crucial
clue
mysteri
evolutionari
tale
sarscov
greatli
strengthen
argument
anim
origin
human
sar
epidem
anoth
interest
result
sarscov
variat
came
wang
group
concept
quasispeci
introduc
sarscov
origin
wellknown
hepat
c
viru
hcv
human
immunodefici
viru
hiv
experiment
evid
suggest
sarsassoci
viru
may
consist
complex
dynam
distribut
mutant
vivo
rather
singl
defin
genom
sequenc
actual
also
reason
genet
variant
sarscov
form
pool
heterogen
viru
individu
patient
owe
poor
fidel
rna
polymeras
recent
zhao
et
al
delin
molecular
insight
crosshost
evolut
sarscov
palm
civet
human
first
genom
sequenc
sarscov
human
palm
civet
outbreak
guangzhou
citi
china
nearli
ident
suggest
independ
viral
invas
anim
human
new
episod
second
virus
palm
civet
suggest
undergo
rapid
evolv
process
much
like
adapt
human
host
earli
epidem
third
major
genet
variat
particularli
spike
gene
might
contribut
greatli
transit
animaltohuman
transfer
humantohuman
transmiss
respons
first
sar
outbreak
context
molecular
interplay
sarscov
host
multipl
line
issu
would
paid
much
attent
includ
immunolog
respons
patholog
respons
etc
would
focu
partner
n
protein
epitop
identif
apoptosi
n
protein
major
structur
compon
virion
appear
involv
multipl
function
viral
rna
replic
translat
far
sever
host
factor
demonstr
bind
n
protein
first
human
cyclophilin
hcypa
demonstr
surfac
plasmon
reson
spr
technolog
interact
partner
furthermor
probabl
bind
model
propos
valid
mutagenesi
experi
may
provid
new
hint
facilit
understand
anoth
possibl
sarscov
infect
pathway
human
cell
heterogen
nuclear
ribonucleoprotein
hnrnp
also
discov
exhibit
high
bind
affin
n
protein
origin
relat
premrna
splice
nucleu
translat
regul
cytoplasm
yeast
twohybrid
assay
combin
gst
pulldown
experi
fine
map
bind
domain
n
protein
hnrnp
recent
group
report
ubiquitin
conjug
enzym
sumoyl
system
interact
specif
n
protein
impli
posttransl
sumoyl
n
protein
avail
host
factor
interact
n
protein
facilit
better
understand
molecular
pathogenesi
sarscov
indic
sever
new
approach
prevent
disrupt
sarscov
infect
cell
essenti
adapt
immun
viral
infect
vivo
cytotox
lymphocyt
ctl
kill
virusinfect
host
cell
recogn
viral
epitop
present
mhc
class
hla
molecul
thu
identif
natur
ctl
epitop
sarscov
would
facilit
better
understand
immunolog
respons
sarscov
infect
human
especi
toward
viru
clearanc
date
ctl
epitop
identifi
mainli
origin
n
protein
sarscov
hla
ctl
epitop
amino
acid
residu
identifi
protein
sarscov
synthet
epitop
polypeptid
rlnevakl
also
stimul
product
peptidespecif
ctl
vivo
transgen
mice
vitro
human
pbl
recent
group
report
novel
hlaa
decamer
epitop
klpddfmgcv
local
within
receptorbind
domain
rbd
protein
significantli
enhanc
express
hlaa
molecul
cell
surfac
stimul
ifngammaproduc
ctl
pbmc
recov
sar
patient
induc
specif
ctl
transgen
mice
vivo
moreov
signific
ctl
induc
mice
immun
dna
vaccin
encod
protein
suggest
natur
process
epitop
apoptosi
one
key
issu
better
understand
molecular
pathogenesi
sar
sarscov
induc
apoptosi
cultur
cell
infect
patient
seri
experiment
evid
indic
sever
viral
compon
sarscov
involv
apoptosi
one
consequ
interplay
sarscov
host
cell
first
three
structur
protein
n
suggest
contribut
induc
apoptosi
differ
cell
line
second
nsp
sarscov
pro
point
function
induc
apoptosi
cell
third
three
accessori
protein
identifi
role
apoptosi
recent
protein
transmembran
protein
unveil
function
ion
channel
might
similar
protein
influenza
viru
indic
possibl
role
releas
packag
matur
viru
particl
also
trigger
apoptosi
vero
cell
support
vitro
experi
chromatin
condens
dna
fragment
protein
poor
document
till
recent
suggest
link
arrest
apoptosi
even
necrosi
follow
transfect
cell
vero
cell
overexpress
induc
apoptosi
via
caspasedepend
pathway
cell
line
deriv
differ
organ
includ
lung
kidney
liver
increasingli
accumul
structur
inform
concern
sarscov
enabl
greatli
elucid
crucial
role
life
cycl
eg
spike
proteinmedi
membran
fusion
proteolyt
process
two
replicas
polyprotein
replicationtranscript
far
crystal
structur
nearli
sarsderiv
protein
obtain
tabl
sarscov
harbor
four
structur
protein
includ
protein
protein
n
protein
e
protein
howev
partial
structur
protein
n
protein
solv
far
protein
member
class
viru
fusion
protein
character
presenc
two
heptad
repeat
hr
region
attach
viru
cellular
receptor
subsequ
trigger
membran
fusion
viru
host
cell
present
crystal
structur
fusion
core
determin
repres
typic
bundl
three
helic
pack
hydrophob
groov
surfac
central
coiledcoil
form
three
parallel
helic
obliqu
antiparallel
manner
structur
avail
fusion
core
make
possibl
design
small
molecul
polypeptid
drug
sar
therapeut
aim
inhibit
viral
entri
block
membran
fusion
ever
success
applic
hiv
therapeut
enfuvertid
recent
two
major
progress
protein
achiev
li
et
al
solv
complex
structur
rbd
protein
bound
peptidas
domain
human
indic
potenti
develop
direct
sar
vaccin
inhibit
small
molecul
crystal
structur
protein
rbd
complex
neutral
monoclon
antibodi
well
defin
provid
structur
rational
major
determin
immunogen
neutral
sarscov
n
protein
play
essenti
role
sarscov
genom
packag
virion
assembl
previou
data
indic
form
dimer
solut
ctermin
domain
crystal
structur
n
protein
dimer
domain
consist
residu
show
dimer
extens
interact
two
subunit
suggest
dimer
form
n
protein
function
unit
vivo
interestingli
although
lack
signific
sequenc
similar
present
fold
mode
similar
n
protein
porcin
reproduct
respiratori
syndrom
viru
prrsv
ie
may
pivot
structur
evid
evolutionari
link
coronavirida
arterivirida
impli
n
protein
virus
common
origin
total
replicas
gene
sarscov
encod
nsp
multipl
enzymat
activ
compos
rnadepend
rna
polymeras
rdrp
chymotrypsinlik
serin
proteas
pro
pro
papainlik
proteas
pro
etc
discuss
nsp
avail
structur
extens
character
one
also
known
pro
mediat
extens
proteolysi
replicas
polyprotein
produc
multipl
function
subunit
involv
gener
replic
complex
function
import
viral
life
cycl
lack
close
relat
cellular
homologu
made
attract
target
develop
drug
sar
infect
shortli
peak
sar
outbreak
rao
group
report
first
time
crystal
structur
sarscov
pro
complex
inhibitor
provid
import
structur
basi
ration
drug
design
also
pose
extens
concern
worldwid
similar
pro
pro
viral
cystein
proteas
sarscov
serv
potenti
antisar
drug
target
recent
crystal
structur
catalyt
core
report
although
overal
architectur
adopt
fold
similar
known
deubiquitin
enzym
also
distinguish
uniqu
featur
includ
intact
zincbind
motif
unobstruct
catalyt
compet
activ
site
presenc
intrigu
ubiquitinlik
ntermin
domain
uniqu
singlestrand
rnabind
protein
implic
viral
rna
synthesi
sarscov
solv
structur
pinpoint
dimer
compris
singl
betabarrel
previous
unknown
fold
analysi
suggest
fold
superfici
resembl
obfold
ctermin
extens
relat
two
subdomain
sarscov
pro
ie
possibl
presum
evolv
proteas
surprisingli
crystal
structur
hexadecamer
supercomplex
sarscov
success
solv
first
possess
novel
golfclub
fold
two
conform
second
complex
uniqu
hollow
cylinderlik
structur
assembl
copi
held
tightli
togeth
copi
third
central
channel
share
dimens
posit
electrostat
properti
turn
favor
nucleicacid
bind
impli
role
replic
transcript
machineri
sarscov
newli
consid
transcript
factor
sarscov
crystal
structur
two
independ
research
group
reveal
novel
fold
first
structur
repres
zinc
finger
protein
found
far
exclus
coronavirus
novel
fold
mean
ident
subunit
assembl
uniqu
spheric
dodecamer
architectur
moreov
gel
shift
assay
indic
bind
singleand
doublestrand
rna
dna
highmicromolar
affin
without
obviou
sequenc
specif
thu
structur
nucleicacid
bind
inform
togeth
high
conserv
zinc
finger
motif
among
coronavirus
make
reason
function
role
transcript
factor
assign
nendou
mn
depend
uridylatespecif
enzym
leav
cyclic
phosphat
cleav
bond
recent
sarscov
unveil
exhibit
uniqu
fold
assembl
toric
hexam
six
potenti
activ
peripher
catalyt
site
structur
combin
spatial
arrang
catalyt
residu
rnase
alik
activ
site
defin
separ
endonucleas
famili
endou
repres
exampl
converg
evolut
toward
enzymat
function
critic
involv
coronaviru
replic
cycl
eight
novel
orf
orf
end
present
sarscov
member
coronaviru
suggest
uniqu
function
might
advantag
sarscov
replic
assembl
virul
date
two
protein
among
socal
accessori
protein
poor
function
assign
elucid
structur
inform
includ
encod
uniqu
type
transmembran
protein
unknown
function
crystal
structur
ntermin
ectodomain
determin
reveal
compact
sevenstrand
beta
sandwich
unexpectedli
similar
fold
topolog
member
ig
superfamili
altern
orf
within
n
gene
sarscov
suggest
encod
lipid
bind
protein
protein
demonstr
share
novel
fold
dimer
tentlik
beta
structur
amphipath
surfac
central
hydrophob
caviti
bind
lipid
molecul
also
associ
intracellular
vesicl
consist
role
viru
assembl
sever
morbid
mortal
associ
sar
make
imper
develop
effect
safe
vaccin
prevent
reemerg
epidem
inactiv
vaccin
may
first
one
avail
clinic
applic
easi
gener
howev
safeti
major
concern
fact
inactiv
sarscov
vaccin
demonstr
elicit
potent
spike
proteinspecif
neutral
antibodi
block
receptor
bind
viru
entri
present
rbd
protein
identifi
contain
multipl
conform
neutral
epitop
impli
potenti
serv
ideal
vaccin
candid
dna
vaccin
encod
glycoprotein
sarscov
induc
cell
neutral
antibodi
respons
well
protect
immun
mous
model
excitedli
use
recombin
adenoassoci
viru
raav
deliveri
system
rbdraav
shown
promis
sar
vaccin
similarli
transgen
plant
eg
tomato
produc
antigen
success
use
mous
model
date
effect
specif
therapeut
measur
use
treat
sar
patient
rna
interfer
rnai
process
introduc
small
interf
rna
sirna
could
caus
degrad
specif
mrna
suggest
work
well
inhibit
sarscov
cultur
cell
anim
wang
et
al
report
plasmidbas
sirna
specif
target
viral
rna
polymeras
block
effect
cytopath
effect
sarscov
vero
cell
effect
specif
express
inhibit
n
protein
observ
sarscovinfect
cell
zhong
group
reveal
sirna
duplex
target
sarscov
genom
rna
potent
agent
inhibit
viral
infect
replic
nonhuman
primat
cell
recent
evalu
sirna
inhibitor
sar
efficaci
safeti
rhesu
macaqu
macaca
mulatta
sar
model
mark
sirnabas
sarscov
inhibitor
one
use
therapeut
agent
util
human
monoclon
antibodi
mab
antisar
therapeut
also
promis
direct
experiment
anim
data
show
protect
sarscov
infect
human
mab
feasibl
eg
combin
two
noncompet
human
mab
potenti
control
immun
escap
extend
breadth
protect
infect
ferret
meanwhil
sever
substanti
progress
also
achiev
design
polypeptid
screen
small
molecul
drug
sar
deng
gao
group
identifi
two
polypeptid
deriv
hr
region
sarscov
present
robust
inhibitori
activ
sarscov
entri
recent
gao
tien
group
also
develop
two
recombin
protein
inhibitor
exhibit
high
stabil
potent
inhibitori
activ
entri
hivsar
pseudovirus
interestingli
two
kind
chines
herbal
medicinederiv
small
molecul
tetraogalloylbetadglucos
tgg
luteolin
identifi
whose
antisarscov
activ
confirm
use
wildtyp
sarscov
infect
system
noteworthi
mention
rao
group
made
major
progress
design
widespectrum
inhibitor
target
coronaviru
sarscov
includ
sar
quickli
conquer
new
infecti
diseas
attract
much
attent
worldwid
thu
extens
document
within
year
sinc
first
discoveri
china
moreov
knowledg
sar
enrich
unprecedentedli
among
sever
event
signific
landmark
fig
howev
still
lot
unclear
sarsrel
issu
desider
solv
alway
case
viru
encount
previous
indic
revers
genet
contribut
function
character
accessori
protein
investig
may
focu
interact
accessori
protein
viral
protein
well
host
factor
lead
better
understand
intric
interplay
sarscov
human
host
also
may
contribut
develop
antivir
therapeut
design
effici
strategi
diseas
control
structur
biolog
combin
xray
crystallographi
demonstr
fruit
address
biomacromolecul
sarscov
typic
first
structur
sarscov
worldwid
pro
avail
shortli
sar
outbreak
well
fusion
core
futur
prospect
sar
structur
biolog
includ
structur
nsp
proteinprotein
complex
favor
understand
sophist
function
assembl
replicationtranscript
machineri
thu
far
effect
vaccin
antivir
drug
avail
sar
therapeut
fortun
sever
candid
remedi
exemplifi
sirna
shown
promis
effect
anim
model
rhesu
macaqu
howev
safeti
effect
clinic
treatment
sar
patient
still
need
evalu
molecular
social
trigger
sarscov
appear
disappear
commun
remain
dogma
need
attract
attent
prevent
sar
emerg
virus
worldwid
